Through the survival analysis, GC patients which have a lower score had a better outcome, with APC co inhibition (Fig. 7D), check point (Fig. 7E), cytolytic activity (Fig. 7F), inflammation promoting (Fig. 7G), MHC class I (Fig. 7H), T cell co inhibition (Fig. 7I), Type II IFN Response (Fig. 7J). The gene discussed is APC; the disease is gastric cancer.